GOLDMAN SACHS INNOVATE EQUITY ETF
62.88
28-February-25 16:30:01
15 minutes delayed
Stocks
+0.31
+0.50%
Today's range
62.11 - 62.88
ISIN
N/A
Source
NYSE
-
Zacks Research Weighs in on BCE's Q3 Earnings (NYSE:BCE)
01 Mar 2025 08:32:14 By Buzz FX
-
Barrington Research Comments on Henry Schein Q3 Earnings
01 Mar 2025 08:32:14 By Buzz FX
-
Zacks Research Has Optimistic Outlook of SPG Q2 Earnings
01 Mar 2025 08:32:14 By Buzz FX
-
Pacira BioSciences (NASDAQ:PCRX) Price Target Raised to $70.00 at HC Wainwright
01 Mar 2025 08:32:14 By Buzz FX
-
Chart Industries, Inc. (NYSE:GTLS) Q4 2024 Earnings Call Transcript
01 Mar 2025 08:31:24 By Buzz FX
-
Tidewater Inc. (NYSE:TDW) Q4 2024 Earnings Call Transcript
01 Mar 2025 08:31:24 By Buzz FX
-
The Goldman Sachs Group Reaffirms Neutral Rating for DoubleVerify (NYSE:DV)
01 Mar 2025 08:31:13 By Buzz FX
-
Personalis (NASDAQ:PSNL) Price Target Lowered to $7.00 at Needham & Company LLC
01 Mar 2025 08:31:13 By Buzz FX
-
Rimini Street (NASDAQ:RMNI) Rating Increased to Buy at Alliance Global Partners
01 Mar 2025 08:31:13 By Buzz FX
-
WPP (NYSE:WPP) Rating Lowered to "Equal Weight" at Barclays
01 Mar 2025 08:31:13 By Buzz FX
-
FY2025 Earnings Estimate for Aritzia Issued By Desjardins
01 Mar 2025 08:26:15 By Buzz FX
-
Q3 EPS Estimate for Atlas Energy Solutions Lifted by Analyst
01 Mar 2025 08:21:14 By Buzz FX
-
Q3 EPS Estimate for Atlanta Braves Reduced by Analyst
01 Mar 2025 08:21:14 By Buzz FX
-
FY2025 EPS Estimates for George Weston Increased by Analyst
01 Mar 2025 08:21:14 By Buzz FX
-
Q3 EPS Forecast for Huron Consulting Group Raised by Analyst
01 Mar 2025 08:21:14 By Buzz FX
-
B. Riley Has Weak Outlook for UMH Properties FY2025 Earnings
01 Mar 2025 08:21:14 By Buzz FX
-
Skyward Specialty Insurance Group (NASDAQ:SKWD) Given Peer Perform Rating at Wolfe Research
01 Mar 2025 08:21:14 By Buzz FX
-
DLocal's (DLO) Equal Weight Rating Reiterated at Morgan Stanley
01 Mar 2025 08:21:14 By Buzz FX
-
MediWound (NASDAQ:MDWD) Now Covered by Analysts at Craig Hallum
01 Mar 2025 08:21:14 By Buzz FX
-
Intellia Therapeutics (NASDAQ:NTLA) Given "Neutral" Rating at JPMorgan Chase & Co.
01 Mar 2025 08:21:14 By Buzz FX